Bajaj Healthcare zooms 20% as Co seeks compulsory licence for Baricitinib ...Middle East

News by : (Business Standard) -
The company has moved the Indian Patent Office requesting to grant a compulsory license for manufacturing & supply of Covid-19 drug "Baricitinib" (API and formulation)

Hence then, the article about bajaj healthcare zooms 20 as co seeks compulsory licence for baricitinib was published today ( ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Bajaj Healthcare zooms 20% as Co seeks compulsory licence for Baricitinib )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار